Lineage, Inc.(LINE)

Search documents
LINE LAWSUIT ALERT: Levi & Korsinsky Notifies Lineage, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Prnewswire· 2025-09-09 13:00
Accessibility StatementSkip Navigation NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lineage, Inc. ("Lineage, Inc." or the "Company") (NASDAQ: LINE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lineage, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of Lineage common stock in or traceable to the registration statement used in connection with t ...
LINE NOTICE: Lineage, Inc. Investors Urged to Contact Kirby McInerney LLP About Securities Fraud Lawsuit
Globenewswire· 2025-09-08 21:26
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ:LINE) investors of the September 30, 2025 to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Lineage securities between July 22, 2024 through August 1, 2025 (“the Class Period”). Follow the link below for more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened? On April 30, 2025, Lineage reported first quar ...
Levi & Korsinsky Notifies Lineage, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – LINE
Globenewswire· 2025-09-08 20:17
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lineage, Inc. ("Lineage, Inc." or the "Company") (NASDAQ: LINE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lineage, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of Lineage common stock in or traceable to the registration statement used in connection with the Company’s July 26, 2024 initial ...
LINEAGE, INC. (NASDAQ: LINE) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Lineage, Inc. Investors of Upcoming Deadline
Globenewswire· 2025-09-08 14:16
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Lineage, Inc. (NASDAQ: LINE)?Did you purchase your shares in, or traceable to, the Company’s July 2024 IPO?Did you lose money in your in ...
Shareholders that lost money on Lineage, Inc.(LINE) should contact The Gross Law Firm about pending Class Action - LINE
Prnewswire· 2025-09-08 12:45
NEW YORK , Sept. 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lineage, Inc. (NASDAQ: LINE). ...
LINE SHAREHOLDERS: Lineage, Inc. Downturn Triggers Class Action -- Contact BFA Law by September 30 if You Lost Money (NASDAQ:LINE)
Globenewswire· 2025-09-08 12:36
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company’s senior executives and directors for potential violations of the federal securities laws. If you invested in Lineage, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/lineage-inc-class-action-lawsuit. Investors have until September 30, 2025, to ask the Court to ...
Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes
Businesswire· 2025-09-08 12:00
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf†, cell therapies for serious medical conditions, today announced the initiation of a new islet cell transplant program in Type 1 Diabetes (T1D). Specifically, the company aims to deploy its manufacturing capability to address the issue of large-scale production of islet cells, with the ini ...
Lineage, Inc. (NASDAQ: LINE) Faces Legal Challenges Amidst Revised Price Targets
Financial Modeling Prep· 2025-09-08 11:00
Scotiabank analyst Greg McGinniss sets a new price target of $43 for NASDAQ:LINE, indicating a potential upside of 5.94%.The stock's volatility is highlighted by its year-long fluctuation between $84.86 and $38.83.Rosen Law Firm encourages investors to seek legal counsel ahead of a lead plaintiff deadline, potentially affecting investor sentiment and stock performance.Lineage, Inc. (NASDAQ: LINE) is a company that has recently caught the attention of investors and analysts alike. On September 5, 2025, Greg ...
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Lineage, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LINE
GlobeNewswire News Room· 2025-09-07 18:15
Core Viewpoint - Rosen Law Firm is reminding purchasers of Lineage, Inc. common stock about the September 30, 2025 lead plaintiff deadline for a class action lawsuit related to the company's July 2024 IPO [1]. Group 1: Class Action Details - Investors who purchased Lineage common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by September 30, 2025 [3]. - The lawsuit claims that the registration statement was false and/or misleading, failing to disclose significant issues affecting Lineage's business operations and financial results [5]. Group 2: Allegations Against Lineage - The lawsuit alleges that Lineage experienced a sustained weakening in customer demand due to increased cold-storage supply and destocking of excessive inventory by customers [5]. - It is claimed that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [5]. - The company reportedly could not counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or falling revenue, occupancy rates, and rent prices [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Rosen Law Firm has been recognized for its leadership in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].
LINE LAWSUIT NOTICE: Lose Money on Lineage, Inc.? Contact BFA Law Prior to September 30 Legal Deadline (NASDAQ:LINE)
GlobeNewswire News Room· 2025-09-06 11:18
Core Viewpoint - A lawsuit has been filed against Lineage, Inc. and its senior executives for potential violations of federal securities laws related to its IPO and subsequent financial performance [1][2]. Group 1: Lawsuit Details - Investors have until September 30, 2025, to request to lead the case, which is based on claims under Sections 11 and 15 of the Securities Act of 1933 [2]. - The lawsuit is pending in the U.S. District Court for the Eastern District of Michigan, specifically titled City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., et al. [2]. Group 2: Company Overview - Lineage, Inc. operates as a cold storage-focused real estate investment trust (REIT), owning and managing temperature-controlled storage facilities for perishable products [3]. Group 3: Allegations and Financial Performance - The IPO documents claimed that Lineage had "consistent cold chain demand" and strong cash flows, suggesting resilience during economic stress, while the reality was a downturn due to customers destocking excess inventory from the pandemic [4]. - Following the IPO on July 25, 2024, at $78 per share, Lineage's stock price has significantly declined to around $40 per share, approximately 50% of its initial value [5].